AlphaMaven AlphaMaven

Eurazeo stock slips after H1 2026 results as investors eye private equity exits - AD HOC NEWS

Reported by Ad-hoc-news
Sep 3, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • Eurazeo stock closed at 48.90 EUR on September 2, 2026, down 1.25% on the day and 4.02% over the past week, underperforming the SBF 120 index amid H1 2026 earnings updates and investor repositioning around private equity exits.
  • • Portfolio value per share increased 3.3% to €105.4 per share in H1 2026, with the firm's asset management division posting strong momentum and exceeding €3.9 billion in portfolio value creation.
  • • Eurazeo closed its fifth-generation secondaries programme at €2.3 billion, exceeding target, with fundraising rising 9% year-over-year to €40 billion, signaling robust capital deployment capacity despite near-term stock pressure.
  • • A planned majority sale of Aroma-Zone natural and DIY beauty business to Partners Group is expected to generate approximately 576 million EUR in gross proceeds for Eurazeo, compared with roughly 410 million EUR invested five years earlier, representing an indicated uplift of approximately 166 million EUR before fees and reinvestment.
  • • Valuation disconnect persists: Morningstar analysts assigned a fair value estimate of 33 EUR per share as of September 1, 2026, while the stock traded at 53.25 EUR, suggesting significant downside risk in analyst assessments versus market pricing.
Summary
Eurazeo's H1 2026 earnings announcement has prompted investor reassessment of the asset manager's valuation, with the stock declining sharply as market participants recalibrate on current-period performance metrics rather than historical benchmarks. The stock closed at 48.90 EUR on September 2, 2026, reflecting a daily loss of 1.25% and a weekly decline of 4.02%, with year-to-date underperformance of 8.26% versus the SBF 120 index. Trading volume remained modest at 68,739 shares on Euronext Paris, suggesting selective investor interest during the earnings reassessment window.

Despite near-term stock weakness, Eurazeo's operational performance in the first half of 2026 demonstrates continued capital generation and deployment capability. Portfolio value per share increased 3.3% to €105.4 per share, reflecting asset appreciation and capital efficiency improvements across the firm's multi-strategy platform. The asset management division confirmed "excellent momentum," with portfolio value creation exceeding €3.9 billion during the half-year period. Fundraising activity accelerated, with the firm closing its fifth-generation secondaries programme at €2.3 billion—surpassing its target—bringing total fundraising to €40 billion, a 9% increase compared to €2.1 billion raised in H1 2025.

Capital recycling remains central to Eurazeo's strategic framework. A material exit is underway through the planned majority sale of the Aroma-Zone natural and DIY beauty business to Partners Group, which is expected to generate approximately 576 million EUR in gross proceeds for Eurazeo. This transaction reflects substantial value creation relative to the firm's historical investment: approximately 410 million EUR was deployed in the asset five years prior, implying a gross uplift of approximately 166 million EUR before fees and reinvestment costs. This deal activity confirms significant exit volumes are anticipated during 2026, supporting the firm's asset rotation strategy.

A material valuation disconnect has emerged between analyst assessments and market pricing. Morningstar data as of September 1, 2026, indicated a fair value estimate of 33 EUR per share, substantially below the 53.25 EUR trading level on that date, suggesting analyst models may reflect elevated exit risk or lower valuation multiples on the firm's diversified portfolio. The stock's sustained underperformance despite strong operational metrics and capital-raising momentum suggests investor caution regarding the magnitude and timing of near-term private equity distributions and overall market sentiment toward alternative asset managers in the current interest rate environment.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Ad-hoc-news Eurazeo stock slips after H1 2026 results as investors eye private equity exits - AD HOC NEWS